Minority of Melanomas With Complete Response to Anti–PD-1 Relapsed After Drug Cessation
More research is needed to define criteria for stopping therapy.
All articles by Leah Lawrence
Cause of Resistance to 3rd-Gen EGFR-TKIs Varied in T790M-Mutated NSCLC
Nonsignificant variation of acquired resistance occurred by drug type.
Aggressive Subtypes of Papillary Thyroid Cancer Deserve Increased Attention
Although papillary thyroid carcinoma subtypes are often lumped together, mortality risk varied greatly across subtypes.
Case Report Details Continued Cancer Treatment During COVID-19 Infection
The patient recovered from pneumonia and stable disease was observed.
Proportion of Women in Oncology Leadership Positions Remains Low
Of 6030 faculty members, 35.9% were women, researchers found.
Lung Cancer Outcomes Worse With ROS1 Fusions and MAPK Pathway Alterations
Optimal combinations of MEK, ROS1 inhibitors should be explored.
Richter Transformation Survival in CLL Appears Better Among Treatment-Naive
Continued investigation of Richter transformation may be warranted as new CLL treatments emerge.
High Radiation Doses May Be Most Effective for Stage I NSCLC
Despite a trend moving toward lower doses of radiotherapy, higher doses may confer a survival benefit.
Adding Tucatinib Improved PFS, OS in Metastatic HER2+ Breast Cancer
Survival benefits were maintained among those with brain metastases.
Afatinib Deemed Active in NSCLC Harboring Uncommon EGFR Mutations
As sequencing becomes more common, data on uncommon EGFR mutations will help guide treatment.
Next post in Lung Cancer
